Ophthalmology

Top Story

BLOG: The goblet cell non-controversy

February 21, 2017

One of the neat things about being on the Rubber Chicken Dinner Circuit of industry-sponsored talks is that you get to hear firsthand what it is that your peers are thinking about and talking about in their practice lives. You also get a sense of how much (or how little) of what you understand as basic knowledge in your own practice is in place out in the wild. It’s especially enlightening when you learn how confusing much of the information that supports the use of our various medicines can be made in the name of marketing.

Take, for example, the importance of goblet cell function in inflammatory dry eye disease (DED). That is to say, in pretty much all of DED. It doesn’t matter what incited the initial inflammation; all of it is going to cause goblet cells to throw up their collective hands and quit doing their job. Your patient, the unsuspecting goblet cell landlord, is then going to suffer the symptoms of DED. Meibomian gland dysfunction, high osmolarity, reduced aqueous production, true allergy or adenoviral infection — it just doesn’t matter. Inflammation rocks goblet cells in a non-“Rock on, dude” way.

Meeting News

Anti-VEGF therapy may not have impact on cataract surgery outcomes in DME patients

February 21, 2017
MIAMI — Anti-VEGF therapy for the treatment of diabetic macular edema does not have a negative impact on patients who undergo cataract surgery, according to a…
Meeting NewsFrom OSN EuropeVideo

VIDEO: Measuring keratoconus progression still challenging

February 21, 2017
MAASTRICHT, Netherlands – At the European Society of Cataract and Refractive Surgeons winter meeting, David Touboul, MD, PhD, speaks about

Glaukos completes enrollment in iStent Supra trial

February 20, 2017
Enrollment in the investigational device exemption trial for the iStent Supra for treatment of patients with open-angle glaucoma and cataracts has been completed…
In the Journals

Achieving Trump’s health care promises would likely require single payer reform

February 20, 2017
President Donald J. Trump’s proposal to replace the Affordable Care Act with a health care law that achieves more coverage, better benefits and lower costs could…
More News Headlines »
Experimental Science

Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma

Ophthalmic Surgery, Lasers and Imaging Retina, February 2017, Volume 48 Issue 2
To describe the ocular toxicity of intravitreal carboplatin and etoposide phosphate (VP16P) in Dutch-Belted rabbits…
More »
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 4

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning…
More »
Featured
Hawaiian Eye/Retina Meeting

Hawaiian Eye/Retina Meeting

From OSN Europe Video
Meeting News

VIDEO: Astigmatism affects multifocal IOL models

February 20, 2017
More »
Advertisement
Advertisement